World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
19257
World Ranking
1988
National Ranking
974

Medicine

D-Index
75
Citations
19331
World Ranking
19162
National Ranking
9555

Overview

David I. Watkins is affiliated with George Washington University in the United States. Their research spans multiple fields within medicine, immunology, and microbiology, with a significant focus on infectious diseases and immunological responses.

The main fields of study they contribute to include:

  • Medicine
  • Immunology and Microbiology

Within these, they explore specialized subfields such as:

  • Immunology
  • Infectious Diseases
  • Virology
  • Public Health, Environmental and Occupational Health
  • Epidemiology

Their work covers key research topics including:

  • HIV Research and Treatment
  • Mosquito-borne diseases and control
  • Immune Cell Function and Interaction
  • Viral Infections and Vectors
  • T-cell and B-cell Immunology
  • Herpesvirus Infections and Treatments
  • Viral Infections and Outbreaks Research

David I. Watkins's research outputs have appeared in a variety of scientific journals. Frequent publication venues are:

  • arXiv (Cornell University)
  • Journal of Virology
  • Frontiers in Immunology
  • Molecular Therapy - Methods & Clinical Development
  • Proceedings of the National Academy of Sciences

Representative research papers authored or co-authored by David I. Watkins include:

  • "Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine," 2020, Proceedings of the National Academy of Sciences
  • "Rectal Acquisition of Simian Immunodeficiency Virus (SIV) SIVmac239 Infection despite Vaccine-Induced Immune Responses against the Entire SIV Proteome," 2020, Journal of Virology
  • "Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies," 2020, Molecular Therapy - Methods & Clinical Development
  • "Plasmablast Expansion Following the Tetravalent, Live-Attenuated Dengue Vaccine Butantan-DV in DENV-Naïve and DENV-Exposed Individuals in a Brazilian Cohort," 2022, Frontiers in Immunology
  • "Immunophenotyping of Rhesus CMV-Specific CD8 T-Cell Populations," 2020, Cytometry Part A

David I. Watkins collaborates regularly with a group of researchers, with frequent co-authors including:

  • Michael J. Ricciardi
  • Eva G. Rakasz
  • Núria Pedreño-López
  • Jeffrey D. Lifson
  • Maurício A. Martins

Best Publications

  • Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.

    Todd M. Allen;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • HIV and SIV CTL escape: implications for vaccine design.

    Philip J. R. Goulder;David I. Watkins

  • Impact of MHC class I diversity on immune control of immunodeficiency virus replication

    Philip J. R. Goulder;David I. Watkins

  • Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers

    Ann J. Hessell;Eva G. Rakasz;Pascal Poignard;Pascal Poignard;Lars Hangartner;Lars Hangartner

  • Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

    David T. Evans;David T. Evans;David H. O'Connor;Peicheng Jing;John L. Dzuris

  • Reversion of CTL escape-variant immunodeficiency viruses in vivo.

    Thomas C Friedrich;Elizabeth J Dodds;Levi J Yant;Lara Vojnov

  • Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L

    Ann J. Hessell;Eva G. Rakasz;David M. Tehrani;Michael Huber

  • Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.

    David H. O'Connor;Todd M. Allen;Thorsten U. Vogel;Peicheng Jing

  • The High-Frequency Major Histocompatibility Complex Class I Allele Mamu-B*17 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Levi J. Yant;Thomas C. Friedrich;Randall C. Johnson;Gemma E. May

  • HIV vaccine research: the way forward.

    Anthony S. Fauci;Margaret I. Johnston;Carl W. Dieffenbach;Dennis R. Burton

  • Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

    David I Watkins;Dennis R Burton;Esper G Kallas;John P Moore

  • Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression.

    Jonah B. Sacha;Chungwon Chung;Eva G. Rakasz;Sean P. Spencer

  • Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

    Danilo R. Casimiro;Fubao Wang;William A. Schleif;Xiaoping Liang

  • Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications

    Huynh Hoa Bui;John Sidney;Bjoern Peters;Muthuraman Sathiamurthy

  • HIV vaccine design: insights from live attenuated SIV vaccines

    Wayne C Koff;Philip R Johnson;David I Watkins;Dennis R Burton

  • Premature Induction of an Immunosuppressive Regulatory T Cell Response during Acute Simian Immunodeficiency Virus Infection

    Jacob D. Estes;Qingsheng Li;Matthew R. Reynolds;Stephen W Wietgrefe

  • Expression of the Major Histocompatibility Complex Class I Molecule Mamu-A*01 Is Associated with Control of Simian Immunodeficiency Virus SIVmac239 Replication

    Bianca R. Mothé;Jason Weinfurter;Chenxi Wang;William Rehrauer

  • Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus.

    Allen Tm;Sidney J;del Guercio Mf;Glickman Rl

  • Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239

    Nancy A. Wilson;Jason Reed;Gnankang S. Napoe;Shari Piaskowski

  • Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239

    Helen Horton;Thorsten U. Vogel;Donald K. Carter;Kathy Vielhuber

Frequent Co-Authors

David H. O’Connor
David H. O’Connor University of Wisconsin–Madison
Todd M. Allen
Todd M. Allen Harvard University
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Alessandro Sette
Alessandro Sette La Jolla Institute For Allergy & Immunology
Ronald C. Desrosiers
Ronald C. Desrosiers University of Miami
Thomas C. Friedrich
Thomas C. Friedrich University of Wisconsin–Madison
David B. Allison
David B. Allison Indiana University
John Sidney
John Sidney La Jolla Institute For Allergy & Immunology
Jonah B. Sacha
Jonah B. Sacha Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology, exploring related nursing degrees can open up diverse opportunities in healthcare. Many professionals start by earning an accelerated BSN, which helps non-nurses quickly gain the foundational skills needed in clinical settings. Programs like accelerated bsn programs for non nurses are designed to make this transition as smooth as possible.

Once foundational nursing skills are gained, specialized roles such as a Family Nurse Practitioner (FNP) become viable. Those with a background in immunology might consider accelerated fnp online programs to expedite their path to advanced practice nursing.

For non-nurses looking to enter the field, online rn programs for non nurses offer flexible study options that accommodate working professionals and help bridge the gap between different healthcare roles.

Additionally, certification in specialized areas is crucial for career growth. Transitioning to roles like acute care nurse practitioner demands specific credentials, including the acute care nurse practitioner certification. This further enhances a nurse’s ability to care for complex patient populations, a valuable skill set in immunology-related healthcare environments.

Best Scientists Citing David I. Watkins

Trending Scientists